Unknown

Dataset Information

0

The PSEN1 I143T mutation in a Swedish family with Alzheimer's disease: clinical report and quantification of A? in different brain regions.


ABSTRACT: Early-onset dominantly inherited forms of Alzheimer's disease (AD) are rare, but studies of such cases have revealed important information about the disease mechanisms. Importantly, mutations in amyloid precursor protein (APP), presenilin 1 (PSEN1) and PSEN2, alter the APP processing and lead to an increased amyloid ?-peptide (A?) 42/40 ratio. This, together with other studies on pathogenic mechanisms, show that A?42 is a major player in the etiology of AD. Here, we present a clinical and neuropathological description of a Swedish family with an I143T mutation in the PSEN1 gene, which gives rise to a severe form of AD. We also performed an extensive investigation on the concentration and distribution of A? species of different lengths in six brain regions from two mutation carriers. Our study showed that A?42 and a longer peptide, A?43, were present both in plaque cores and in total amyloid preparations, and were each clearly more frequent than A?40 in all examined regions, as shown by both mass spectrometry and immunohistochemistry.

SUBMITTER: Keller L 

PROVIDER: S-EPMC2987466 | biostudies-literature | 2010 Nov

REPOSITORIES: biostudies-literature

altmetric image

Publications

The PSEN1 I143T mutation in a Swedish family with Alzheimer's disease: clinical report and quantification of Aβ in different brain regions.

Keller Lina L   Welander Hedvig H   Chiang Huei-Hsin HH   Tjernberg Lars O LO   Nennesmo Inger I   Wallin Asa K AK   Graff Caroline C  

European journal of human genetics : EJHG 20100714 11


Early-onset dominantly inherited forms of Alzheimer's disease (AD) are rare, but studies of such cases have revealed important information about the disease mechanisms. Importantly, mutations in amyloid precursor protein (APP), presenilin 1 (PSEN1) and PSEN2, alter the APP processing and lead to an increased amyloid β-peptide (Aβ) 42/40 ratio. This, together with other studies on pathogenic mechanisms, show that Aβ42 is a major player in the etiology of AD. Here, we present a clinical and neurop  ...[more]

Similar Datasets

2015-12-05 | GSE42745 | GEO
2015-12-05 | E-GEOD-42745 | biostudies-arrayexpress
| S-EPMC7151116 | biostudies-literature
| S-EPMC4606562 | biostudies-literature
| S-EPMC4019728 | biostudies-literature
| S-EPMC6685246 | biostudies-literature
| S-EPMC7345614 | biostudies-literature
| S-EPMC6511480 | biostudies-literature
| S-EPMC4753688 | biostudies-literature
| S-EPMC7366492 | biostudies-literature